Valneva starts with Phase 3 trial for booster vaccination
On 25th of January Valneva SE announced the start of booster vaccinations in adult participants from its Phase 3 pivotal trial, Cov-Compare. This booster extension is intended to provide both homologous and first heterologous booster [...]